Presentation THT 2024 Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance Presenter: Jeffrey Testani March 06, 2024
Presentation THT 2024 A Novel Cardiac Scale and Algorithm for Detecting Worsening Congestion Preceding Heart Failure Events (HFEs): A Preliminary Analysis of the SCALE-HF 1 Study Presenter: Marat Fudim March 06, 2024
Presentation THT 2024 Cardiac Contractility Modulator as an Option for Advanced Heart Failure Patients Dependent on Low Dose inotropes Presenter: Kanika P. Mody March 06, 2024
Presentation THT 2024 Impact of Noninvasive, Low-Intensity Ultrasound Energy Delivery to the Kidney on Urine Output in Acutely Decompensated Heart Failure Patients Presenter: Benny Rousso March 06, 2024
Presentation THT 2024 Acute and Chronic Outcomes in Early Feasibility Evaluation of Device-Based Thoracic Duct Decompression in Hospitalized Acute Decompensated Heart Failure Patients Presenter: William T. Abraham March 06, 2024
Presentation THT 2024 Transcatheter pulmonary artery banding [PAB] for HFrEF: Initial results of invasive exercise hemodynamics and updates from the ongoing First-in-Human trial. Presenter: Sean P. Pinney March 06, 2024
Presentation THT 2024 Preliminary Results from the Early Feasibility Study of the FIRE1 System in Heart Failure Patients Presenter: Nir Uriel March 06, 2024
Presentation THT 2024 Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics Presenter: Lucas Zier March 06, 2024
Presentation THT 2024 Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure Presenter: Liviu Klein March 05, 2024
Presentation THT 2024 Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial Presenter: David M. Kaye March 05, 2024
Presentation THT 2024 Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve post-LVAD Reverse Cardiac Remodeling Presenter: Stavros G. Drakos March 05, 2024
Presentation THT 2024 The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions Presenter: Kevin Makati March 05, 2024
Presentation THT Abstracts 2024 Beyond Supine Pulmonary Artery Pressures Presenter: Marat Fudim March 05, 2024
Presentation THT Abstracts 2024 Does Guideline-Directed Medical Therapy Improve Outcomes in HeartMate 3 Patients? Presenter: Julia Baranowska March 05, 2024
Presentation THT Abstracts 2024 Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group Presenter: Kevin John March 05, 2024
Presentation THT Abstracts 2024 Duration of Intra-Aortic Entrainment Pump Therapy and Clinical Outcomes in Acute Decompensated Heart Failure and Cardiorenal Syndrome Presenter: Matteo Fabbri March 05, 2024
Presentation THT Abstracts 2024 Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF) Presenter: Alexandra Steverson March 05, 2024